Vitoria

• A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM 201 in Naïve-to-Tr … Not authorised
  2025-523820-26-00 5 Growth Hormone Deficiency (GHD)
• Utility of the use of N-acetylcisteine associated with conventional treatment in patients with severe acute alcoholic hepatitis (Maddrey>=32 … Pending
  2023-510163-35-00 5 Acute Alcoholic hepatitis
• A randomized, double blind, double dummy, parallel group, multicenter clinical trial to evaluate the safety and clinical and microbiologic e … Pending
  2024-518646-24-00 11 Uncomplicated urinary tract infection (uUTI)
• Randomized clinical trial to assess the efficacy and safety of a strategy for primary prevention of cardiovascular disease in patients with … Pending
  2025-521086-28-00 6 CHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arthritis or psoria
• A Phase 3, Long-Term Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Zasocitinib in Subjects with Active Pso … Pending
  2025-522586-30-00 5 Psoriatic Arthritis
• Clinical Study to Evaluate the Effects of Cevostamab in Patients with Lupus with or without Active Lupus Nephritis Pending
  2025-522904-26-00 3 Systemic Lupus Erythematosus (SLE) With or Without Active Lupus Nephri
• A study to evaluate the efficacy and safety of belantamab mafodotin in combination with standard of care in participants aged 18 years and o … Pending
  2025-523117-28-00 4 Relapsed or Refractory Multiple Myeloma
• A study to test whether different doses of BI 3000202 help people with systemic lupus erythematosus (SLE) Pending
  2025-523488-39-00 4 Systemic lupus erythematosus
• A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 Pending
  2025-523911-13-00 5 Narcolepsy Type 1
• A Phase 3 Single-arm Study of UGN-104 for the Treatment of LG-UTUC Recruiting
  2024-519343-15-00 5 2025-10-08 Low-grade Upper Tract Urothelial Cancer
• A study to find how well Dazodalibep works and how safe it is in participants with Sjôgren`s Syndrome Recruiting
  2023-503904-10-00 5 2024-06-07 Sjögren’s Syndrome With Moderate-to-severe Systemic Disease Activity
• Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants with HPP Recruiting
  2023-505675-73-00 5 2024-04-26 hypophosphatasia
• Study to evaluate the efficacy and safety of supportive mitomycin C administered via electric current in the treatment of non-muscle invasiv … Recruiting
  2024-520006-19-00 6 2021-12-15 Non-muscle invasive bladder cancer
• CLINICAL TRIAL TO EVALUATE BLADDER INSTILLATION OF NEOADJUVANT CHEMOTHERAPY TO TRANSURETHRAL RESECTION OF THE BLADDER FOR THE PREVENTION OF … Recruiting
  2024-512683-53-00 6 2018-05-18 Non-muscle invasive bladder cancer
• AMAZE 4: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight and obstructive sleep apnoea … Recruiting
  2024-520443-16-00 5 2026-05-04 Overweight or obesity, and obstructive sleep apnoea treated with posit
• AMAZE 3: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight and obstructive sleep apnoea … Recruiting
  2024-520442-36-00 5 2026-04-30 Overweight or obesity, and obstructive sleep apnoea not treated with p
• A Long-term Extension Study of ORX750 in Participants with Narcolepsy and Idiopathic Hypersomnia Recruiting
  2025-522987-34-00 4 2026-03-13 Narcolepsy and Idiopathic Hypersomnia
• Phase Ib-II, non-randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz) concomitant with modFOLFIRINOX for front-line trea … Recruiting
  2024-511459-16-00 9 2025-10-14 Histologically confirmed pancreatic adenocarcinoma with liver metastas
• Open-Label followed by a Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Infigratinib in Children with Hypo … Recruiting
  2024-516822-67-00 10 2025-08-14 Hypochondroplasia
• A Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects with Active Psoriatic Arthritis Stratified by Prior … Recruiting
  2024-513112-99-00 5 2025-06-13 Active Psoriatic Arthritis Stratified by Prior Biologic Use
• A Study of ORX750 in Subjects with Narcolepsy and Idiopathic Hypersomnia Recruiting
  2024-518929-15-00 4 2025-06-09 Narcolepsy and Idiopathic Hypersomnia
• A Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of TAK-360 in Participants with IH Recruiting
  2024-517712-29-00 4 2025-05-27 Idiopathic Hypersomnia (IH)
• Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis (SchizOMICS) Recruiting
  2024-516768-28-00 6 2024-12-16 Schizophrenia
• A study to learn if dapirolizumab pegol works and is safe in people with moderately to severely active systemic lupus erythematosus (SLE) Recruiting
  2023-508191-11-00 5 2024-11-28 Systemic lupus erythematosus (SLE)

Showing 1–24 of 58 trials